REsistance and LOADing Exercise for Bone Health
NCT07817381
Summary
Lower limb amputation, often resulting from military conflict and road traffic accidents, is associated with reduced hip bone mineral density (BMD) and increased risk of hip fractures. This bone loss is attributed to altered mechanical loading and is compounded by an increased falls risk in prosthesis users. While resistance and high-impact exercise interventions have proven effective in enhancing BMD in other populations, no studies have examined their role in amputees. Building on an international Delphi consensus guidelines, this study aims to assess the feasibility and safety of a novel home-based, tele-supervised resistance and high-impact exercise intervention in individuals with unilateral transtibial limb loss. A convenience sample of 10 male prosthesis wearers from the ongoing ADVANCE Study will be involved in the study for 10 weeks and will undertake an 8-week, twice-weekly exercise program including resistance (squat, deadlift, overhead press) and impact-based activities (e.g., multidirectional jumps) (week 2 to week 9 of the study participation). Remote supervision will be provided twice weekly during the first week of exercise and once weekly thereafter. The primary outcomes are feasibility (recruitment, retention, compliance, acceptability, tolerance) and safety (adverse event monitoring). Secondary outcomes include changes in hip muscle strength and neuromuscular performance, assessed at baseline (week 1 of the study participation) and post-intervention (week 10 of the study participation) using isokinetic dynamometry, and force plates, respectively. This study will provide the first evidence on the feasibility and safety of a targeted exercise intervention to stabilise or improve BMD in unilateral transtibial amputees. Findings will inform the design of a subsequent randomised controlled trial to evaluate efficacy, with potential to shape clinical rehabilitation programmes for military and civilian amputee populations at risk of low BMD and related complications.
Eligibility
Inclusion Criteria: * Current or previous British Armed Forces Personnel who are members of the ADVANCE Study (Bennett et al., 2020) * Male * Aged ≥ 18 years and ≤ 55 years * History of unilateral below knee limb loss due to trauma * Ambulating with their current prosthetic limb for a minimum of six months * Full-time prosthesis wearer (i.e., wearing the prosthesis every day, for most of the day, removing it mainly for sleeping or when resting for extended periods) * Able to walk independently using a prosthetic limb * Able to perform jumping activities on the prosthetic limb * Able to communicate in English * Access to the internet and a computer/smartphone * Able to drive/be driven to and from the testing location for the purpose of transporting the exercise equipment provided by the research team Exclusion Criteria: * Additional limb loss of the upper and/or lower limb other than the transtibial limb loss * Cardiovascular disease, diabetes, neurological injury * Sickle cell disease * Neurodegenerative disease * Limb loss as a result of a vascular condition * Orthopaedic or neurological issues in the intact/non-amputated limb * Additional neuromusculoskeletal pathology which may affect walking * Pain, irritation, swelling, or skin complaints in the residual limb which inhibit prosthetic use * Diseases affecting bone metabolism (other than osteoporosis/osteopenia; for example, osteomalacia, Paget's disease, hyper/hypoparathyroidism, osteogenesis imperfecta) * Traumatic head injury resulting in cognitive disability * Lack of capacity to give consent * Any contraindications to exercise and/or resistance training * Continuous immobilisation for seven days or more in the month prior to attendance * Use of assistive walking device when utilising the, other than a prosthetic limb * Unable to regularly attend the supervised training program
Conditions4
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT07817381